Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT00000362
Other study ID # NIDCD-1159
Secondary ID Protocol 201UO1
Status Terminated
Phase Phase 3
First received November 2, 1999
Last updated April 21, 2006
Est. completion date January 2006

Study information

Verified date April 2006
Source National Institute on Deafness and Other Communication Disorders (NIDCD)
Contact n/a
Is FDA regulated No
Health authority United States: Federal Government
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine whether chin-down posture or use of a thickened liquid diet is more effective in the prevention of aspiration and aspiration pneumonia in patients with Parkinson's disease and/or dementia. Liquid aspiration is the most common type of aspiration in older populations, especially those suffering from debilitation, dementia, and depression. Pneumonia may develop as a consequence of aspiration and is the fifth leading cause of death in the US among persons age 65 years and over. Current treatment involves either use of chin-down position with swallowing or use of thickened liquids in the diet, without any clear evidence supporting the use of one treatment over the other. This is a Phase III inpatient and/or outpatient study in which all participants will be randomly assigned to either the chin-down position or the thickened liquid treatment group based on swallowing function during a modified barium swallow. This study is scheduled to recruit patients for a three-year period; participation by each individual patient spans no more than three months after entry.


Recruitment information / eligibility

Status Terminated
Enrollment 600
Est. completion date January 2006
Est. primary completion date
Accepts healthy volunteers No
Gender Both
Age group 50 Years to 95 Years
Eligibility Inclusion Criteria:

- Have dementia or Parkinson's disease and are found to aspirate on thin liquid during a set of qualifying swallows.

Exclusion Criteria:

- Have smoked more than a pack of cigarettes per day in the last year.

- Drink more than 3 alcoholic beverages per day on a regular basis.

- Have had any head and neck cancer treatment.

- Have any head and neck anatomic deformities.

- Have a history of 20 years or longer of insulin-dependent diabetes.

- Have other exclusionary neurologic diagnoses.

- Have had pneumonia within 6 weeks of screening.

- Currently have a nasogastric tube.

- Currently have a tracheotomy.

- Are a resident in non-participating nursing home or assisted living environment.

- Live alone.

- Have no regular care provider present at meals.

- Have no Speech-Language Pathologist to provide a 3-month follow-up.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention


Related Conditions & MeSH terms


Intervention

Behavioral:
Chin-down position

Thickened liquid administration


Locations

Country Name City State
United States University of Wisconsin at Madison & multiple other U.S. locations Madison Wisconsin

Sponsors (1)

Lead Sponsor Collaborator
National Institute on Deafness and Other Communication Disorders (NIDCD)

Country where clinical trial is conducted

United States, 

See also
  Status Clinical Trial Phase
Terminated NCT00005776 - Inhaled Nitric Oxide Study for Respiratory Failure in Newborns Phase 3
Completed NCT06154486 - Evaluation of Gastric Content of Volunteers Fasting and Using Semaglutide: an Observational and Cross-sectional Study
Withdrawn NCT02301845 - Validation of Aspiration Markers Phase 1
Completed NCT01301352 - Feeding Children Nasogastrically Versus Nasojejunally While Receiving Noninvasive Positive Pressure Ventilation N/A
Completed NCT01045902 - BAY12-8039, iv/Oral Pulmonary Abscess/Aspiration Pneumonia Phase 3
Recruiting NCT05728242 - Point-of-care Gastric Ultrasound for Fracture Surgery
Terminated NCT00005773 - Early Inhaled Nitric Oxide for Respiratory Failure in Newborns Phase 3